Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Invivyd Inc (IVVD)

Invivyd Inc (IVVD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,538
  • Shares Outstanding, K 119,961
  • Annual Sales, $ 25,380 K
  • Annual Income, $ -169,930 K
  • EBIT $ -177 M
  • EBITDA $ -174 M
  • 60-Month Beta 0.41
  • Price/Sales 2.43
  • Price/Cash Flow N/A
  • Price/Book 0.91
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.44
  • Most Recent Earnings $-0.15 on 03/20/25
  • Next Earnings Date 05/08/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Options Overview Details

View History
  • Implied Volatility 191.02% ( -269.23%)
  • Historical Volatility 83.64%
  • IV Percentile 30%
  • IV Rank 19.55%
  • IV High 877.55% on 11/18/24
  • IV Low 24.16% on 05/13/24
  • Put/Call Vol Ratio 0.22
  • Today's Volume 303
  • Volume Avg (30-Day) 228
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 6,794
  • Open Int (30-Day) 6,548

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.04
  • Number of Estimates 2
  • High Estimate -0.02
  • Low Estimate -0.06
  • Prior Year -0.38
  • Growth Rate Est. (year over year) +89.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4600 +10.87%
on 04/07/25
0.8963 -43.10%
on 03/20/25
-0.2542 (-33.26%)
since 03/17/25
3-Month
0.3546 +43.82%
on 01/30/25
2.7400 -81.39%
on 02/06/25
+0.1036 (+25.49%)
since 01/17/25
52-Week
0.3546 +43.82%
on 01/30/25
2.7400 -81.39%
on 02/06/25
-1.9700 (-79.44%)
since 04/17/24

Most Recent Stories

More News
Invivyd Appoints Ajay Royan, Founder of Mithril Capital, to its Board of Directors

IVVD : 0.5100 (+8.21%)
Invivyd Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Recent Business Highlights

IVVD : 0.5100 (+8.21%)
Invivyd Announces Continued Neutralizing Activity of PEMGARDAâ„¢ (pemivibart) Against Currently Dominant SARS-CoV-2 Variant LP.8.1

IVVD : 0.5100 (+8.21%)
The Zacks Analyst Blog Highlights INVIVYD, 21Vianet, FuboTV, Noodles and Digital Turbine

For Immediate ReleaseChicago, IL – February 25, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and...

NDLS : 0.8850 (+5.34%)
IVVD : 0.5100 (+8.21%)
APPS : 3.12 (+9.09%)
FUBO : 2.99 (+4.18%)
VNET : 5.02 (+5.91%)
5 Stocks That More Than Doubled Halfway Through Q1

After a weak start to 2025, Wall Street regained momentum, driven by solid corporate earnings and advancements in AI. The S&P 500 touched record highs on several occasions, having risen 2.2%, while the...

NDLS : 0.8850 (+5.34%)
IVVD : 0.5100 (+8.21%)
APPS : 3.12 (+9.09%)
FUBO : 2.99 (+4.18%)
VNET : 5.02 (+5.91%)
FDA Declined Invivyd’s Request to Expand Existing Emergency Use Authorization of PEMGARDA™ (pemivibart) to Include Treatment of Mild-to-Moderate COVID-19 For Immunocompromised Persons Who Have No Alternative Therapeutic Options; No Change to the...

IVVD : 0.5100 (+8.21%)
These 5 Health Care Stocks Saw The Sharpest Retail Interest Jump Last Week

These five small-cap pharma and biotech stocks drew heavy attention on Stocktwits last week, driven by key trial results, FDA updates, and promising drug developments.

MBX : 7.62 (+1.46%)
GHRS : 9.10 (+4.60%)
IVVD : 0.5100 (+8.21%)
RANI : 1.1700 (+1.74%)
LIPO : 2.40 (-0.41%)
Invivyd to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 12, 2025

IVVD : 0.5100 (+8.21%)
This Penny Stock Just Doubled on Clinical Trial Results. Analysts Think It Can Surge 266% From Here.

Investors could consider this penny stock after its COVID-19 antibody breakthrough sent shares soaring, and analysts see massive triple-digit gains ahead.

-MEBI : -32.51 (+4.66%)
IVVD : 0.5100 (+8.21%)
Invivyd Announces Partnership with Pro Football Coach Jim Harbaugh to Elevate Awareness and Ongoing Impact of COVID-19: Common, Not A Cold

IVVD : 0.5100 (+8.21%)

Business Summary

INVIVYD INC. is a biopharmaceutical company. It involved in developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. INVIVYD INC., formerly known as Adagio Therapeutics, is based in WALTHAM, Mass.

See More

Key Turning Points

3rd Resistance Point 0.5565
2nd Resistance Point 0.5333
1st Resistance Point 0.5216
Last Price 0.5100
1st Support Level 0.4867
2nd Support Level 0.4635
3rd Support Level 0.4518

See More

52-Week High 2.7400
Fibonacci 61.8% 1.8288
Fibonacci 50% 1.5473
Fibonacci 38.2% 1.2658
Last Price 0.5100
52-Week Low 0.3546

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar